ABCC7 p.Leu102Pro

[switch to full view]
Comments [show]
Publications
PMID: 21708286 [PubMed] Fresquet F et al: "Orphan missense mutations in the cystic fibrosis transmembrane conductance regulator a three-step biological approach to establishing a correlation between genotype and phenotype."
No. Sentence Comment
43 Patient 1 was a 3-year-old girl when the CF diagnosis was established, with a genotype as follows: p.[Leu102Pro] ϩ [Arg553X].
X
ABCC7 p.Leu102Pro 21708286:43:102
status: NEW
Login to comment

95 Results Defective Activation and Maturation of L102P and L167R CFTR Mutants Details of the six patients, their genotypes and phenotypes, and characteristics of their CFTR mutations are provided (Table 2).
X
ABCC7 p.Leu102Pro 21708286:95:47
status: NEW
Login to comment

97 Sequences of Site-Directed Mutagenesis Primers Mutation Sense oligonucleotide sequences L102P 5=-GTACAGCCTCTCTTACCGGGAAGAATCATAGCTTCC-3= L167R 5=-AAGAAGACTTTAAAGCGGTCAAGCCGTGTTCTAG-3= P574S 5=-GCTGATTTGTATTTATTAGACTCTTCTTTTGGATACCTAGATG-3= V562I 5=-AGAATTTCTTTAGCAAGAGCAATATACAAAGATGCTGATTTG-3= K696R 5=-CAGACTGGAGAGTTTGGGGAAAGAAGGAAGAATTCTATTCTC-3= P841R 5=-GATATGGAGAGCATACGAGCAGTGACTACATGG-3= CFTR Missense Mutation Biological Assay 3 JMD Month 2011, Vol. xx, No.
X
ABCC7 p.Leu102Pro 21708286:97:88
status: NEW
Login to comment

98 x 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 AQ: 15 AQ: 16 AQ:17-18 AQ: 19 AQ: 20 T1 AQ: 21 AQ: 22 AQ: 23 AQ: 24 AQ: 25 AQ: 26 AQ: 27 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 AQ: 28 AQ: 29 AQ: 30 T2 variants that we investigate herein, two affect membrane-spanning domain 1: p.[Leu102Pro] (L102P) and p.[Leu167Arg] (L167R).
X
ABCC7 p.Leu102Pro 21708286:98:683
status: NEW
X
ABCC7 p.Leu102Pro 21708286:98:695
status: NEW
Login to comment

100 Thus, L102P and L167R mutants appear unable to escape the ER.
X
ABCC7 p.Leu102Pro 21708286:100:6
status: NEW
Login to comment

104 Although 100% activation is attributed to the maximal activation peak of WT-CFTR, activation is reduced to 7.45% Ϯ 3.76% (n ϭ 4) for L102P and to 27.84% Ϯ 1.96% (n ϭ 4) for L167R.
X
ABCC7 p.Leu102Pro 21708286:104:145
status: NEW
Login to comment

122 Summary of the Patients` Data, Concerning Genotype, Phenotype, and Protein Dysfunction Patient no./sex/age at molecular diagnostics (years) Genotype Phenotype Protein dysfunctions Channel activity* Maturation† Intracellular localization‡ 1/F/3 p.[Leu102Pro] ϩ [Arg553X] Positive sweat test result, bacterial lung colonization, no pancreatitis ϩϩ ϩϩ ϩϩ 2/F/newborn p.[Phe508del] ϩ [Leu167Arg] Positive sweat test result, recurrent pancreatitis, no lung infection ϩϩ ϩϩ ϩϩ 3/F/3 p.[Asn1303Lys] ϩ [Pro574Ser] Normal sweat test result, asymptomatic ϩϩ ϩ ϩ 4/M/31 p.[Arg74Trp;Val201Met; Asp1270Asn] ϩ [Pro841Arg]; c.
X
ABCC7 p.Leu102Pro 21708286:122:261
status: NEW
Login to comment

133 After using Western blot analysis (Figure 3B), the proportions of core-glycosylated protein for K696R and P841R appear insignificantly different from that of WT-CFTR (n ϭ 3, data not shown).
X
ABCC7 p.Leu102Pro 21708286:133:47
status: NEW
Login to comment

134 Moreover, we observe by iodide efflux experiments that both mutations have similar functional consequence on CFTR activity: the maximum activation is reduced to 49.67% Ϯ 2.61% (n ϭ 4) for K696R and to 45.10% Ϯ 4.94% (n ϭ 4) for P841R (Figure 3C).
X
ABCC7 p.Leu102Pro 21708286:134:106
status: NEW
X
ABCC7 p.Leu102Pro 21708286:134:117
status: NEW
Login to comment

151 In our model, two missense mutations, L102P and A calreticulin egremP201L calreticulin egremP201L L167R calreticulin mergeL167R calreticulin merge CB F508del L102P L167R WT F508del L102P L167R *** *** ***WT + inh172 L102P L167R *** *** ***WT + inh172 L102P L167R B C CFTR B C CFTR % of maximal activation C.
X
ABCC7 p.Leu102Pro 21708286:151:38
status: NEW
X
ABCC7 p.Leu102Pro 21708286:151:158
status: NEW
X
ABCC7 p.Leu102Pro 21708286:151:181
status: NEW
X
ABCC7 p.Leu102Pro 21708286:151:216
status: NEW
X
ABCC7 p.Leu102Pro 21708286:151:251
status: NEW
Login to comment

154 L102P and L167R amino acid substitutions impair CFTR protein maturation.
X
ABCC7 p.Leu102Pro 21708286:154:0
status: NEW
Login to comment

172 One of these patients, with severe respiratory tract symptoms and long-term lung colonization, was diagnosed as having CF; his genotype is p.[Leu102Pro] ϩ [Arg553X].
X
ABCC7 p.Leu102Pro 21708286:172:142
status: NEW
Login to comment

173 This finding is in accordance with the dramatically reduced activity that we found for L102P-CFTR protein in cell culture.
X
ABCC7 p.Leu102Pro 21708286:173:87
status: NEW
Login to comment

175 The L167R allele exhibits, as described for L102P, a maturation and trafficking defect leading to a sharp decrease of CFTR activity compared with that of WT-CFTR.
X
ABCC7 p.Leu102Pro 21708286:175:44
status: NEW
Login to comment

176 Nevertheless, iodide efflux experiments on L167R exhibit a residual activity slightly more elevated (27.84%) than that for L102P (7.45%).
X
ABCC7 p.Leu102Pro 21708286:176:123
status: NEW
Login to comment

183 Contrary to L102P and L167R, P574S is not fully retained in the ER compartment because we can see the presence of the fully glycosylated mature form of CFTR by using Western blot analysis.
X
ABCC7 p.Leu102Pro 21708286:183:12
status: NEW
X
ABCC7 p.Leu102Pro 21708286:183:87
status: NEW
Login to comment

185 Taken together, these results strengthen the idea that a small part of P574S could reach post-Golgi compartments and, thus, the plasma membrane.
X
ABCC7 p.Leu102Pro 21708286:185:44
status: NEW
Login to comment

193 K696R and P841R amino acid substitutions affect CFTR channel activity.
X
ABCC7 p.Leu102Pro 21708286:193:12
status: NEW
Login to comment

60 Sequences of Site-Directed Mutagenesis Primers Mutation Sense oligonucleotide sequences L102P 5=-GTACAGCCTCTCTTACCGGGAAGAATCATAGCTTCC-3= L167R 5=-AAGAAGACTTTAAAGCGGTCAAGCCGTGTTCTAG-3= P574S 5=-GCTGATTTGTATTTATTAGACTCTTCTTTTGGATACCTAGATG-3= V562I 5=-AGAATTTCTTTAGCAAGAGCAATATACAAAGATGCTGATTTG-3= K696R 5=-CAGACTGGAGAGTTTGGGGAAAGAAGGAAGAATTCTATTCTC-3= P841R 5=-GATATGGAGAGCATACGAGCAGTGACTACATGG-3= was presented.
X
ABCC7 p.Leu102Pro 21708286:60:88
status: NEW
Login to comment

72 A calreticulin egremP201L calreticulin egremP201L L167R calreticulin mergeL167R calreticulin merge CB F508del L102P L167R WT F508del L102P L167R *** *** ***WT + inh172 L102P L167R *** *** ***WT + inh172 L102P L167R B C CFTR B C CFTR % of maximal activation 0 50 100 WT 0 50 100 WTNaKATPaseNaKATPase Figure 1.
X
ABCC7 p.Leu102Pro 21708286:72:110
status: NEW
X
ABCC7 p.Leu102Pro 21708286:72:133
status: NEW
X
ABCC7 p.Leu102Pro 21708286:72:168
status: NEW
X
ABCC7 p.Leu102Pro 21708286:72:203
status: NEW
Login to comment

73 L102P and L167R amino acid substitutions impair CFTR protein maturation.
X
ABCC7 p.Leu102Pro 21708286:73:0
status: NEW
Login to comment

81 Summary of the Patients` Data, Concerning Genotype, Phenotype, and Protein Dysfunction Patient no./sex/age at molecular diagnostics (years) Genotype Phenotype Protein dysfunctions Channel activity* Maturation† Intracellular localization‡ 1/F/3 p.[Leu102Pro] ϩ [Arg553X] Positive sweat test result, bacterial lung colonization, no pancreatitis ϩϩ ϩϩ ϩϩ 2/F/newborn p.[Phe508del] ϩ [Leu167Arg] Positive sweat test result, recurrent pancreatitis, no lung infection ϩϩ ϩϩ ϩϩ 3/F/3 p.[Asn1303Lys] ϩ [Pro574Ser] Normal sweat test result, asymptomatic ϩϩ ϩ ϩ 4/M/31 p.[Arg74Trp;Val201Met; Asp1270Asn] ϩ [Pro841Arg]; c.
X
ABCC7 p.Leu102Pro 21708286:81:261
status: NEW
Login to comment

136 Thus, L102P and L167R mutants appear unable to escape the ER.
X
ABCC7 p.Leu102Pro 21708286:136:6
status: NEW
Login to comment

140 When 100% activation is attributed to the maximal activation peak of WT-CFTR, activation is reduced to 7.45% Ϯ 3.76% (n ϭ 4) for L102P and to 27.84% Ϯ 1.96% (n ϭ 4) for L167R.
X
ABCC7 p.Leu102Pro 21708286:140:141
status: NEW
Login to comment

179 In our model, two missense mutations, L102P and L167R, exhibit an F508del-like phenotype: the proteins are blocked at the ER level, and their absence at the plasma membrane elicits reduced channel activity.
X
ABCC7 p.Leu102Pro 21708286:179:38
status: NEW
Login to comment

182 One of these patients, with severe respiratory tract symptoms and long-term lung colonization, was diagnosed as having CF; his genotype is p.[Leu102Pro] ϩ [Arg553X].
X
ABCC7 p.Leu102Pro 21708286:182:142
status: NEW
Login to comment

186 Nevertheless, iodide efflux experiments on L167R exhibit a residual activity slightly more elevated (27.84%) than that for L102P (7.45%).
X
ABCC7 p.Leu102Pro 21708286:186:123
status: NEW
Login to comment